Terns Pharmaceuticals logo
VerifiedBiotechnology Research· Founded 2017

Terns Pharmaceuticals

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit:

7-day free trial · no credit card

HeadquartersFoster City, United StatesEmployees64(51 to 200)Annual revenue$10M to <$50MFounded year2017Websiteternspharma.comLinkedIn profileLinkedIn

Verified contacts

54

available on Kipplo

LinkedIn employees

64

51 to 200 range

Open roles

no listings

Distinct roles

38

indexed titles

Tech stack

4

tools in use

Monthly traffic

388

organic / mo

Sign up free to see all 54 verified contacts at Terns Pharmaceuticals

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

54 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Terns Pharmaceuticals

38 distinct titles indexed · top 10 shown.

  • 3, -
  • 2()
  • 2senior director
  • 1,,
  • 1associate director
  • 1associate director clinical operations
  • 1associate director, cmc (drug substance)
  • 1associate director, nonclinical development
  • 1board chair
  • 1chief executive officer
  • +28more titles

Sign up to unlock all 54 contacts at Terns Pharmaceuticals

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 54 verified contacts at Terns Pharmaceuticals

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Terns Pharmaceuticals | Kipplo Discover